D
uring the past two decades, infectious complications of blood transfusion have dramatically decreased. 1 In the meantime, noninfectious complications have become a growing concern. Transfusion-associated circulatory overload (TACO) is a severe acute complication of transfusion. The patients typically experience dyspnea, cyanosis, orthopnea, and hypertension during or within the 6 hours of a transfusion. If untreated, it can cause hypoxemic cardiac arrest and it is currently considered the leading cause of transfusionrelated death. 2 Incidence rates of TACO reported by hemovigilance systems widely vary among and within countries, ranging from 0.40 to 16 .64 per 100,000 transfused units and is certainly underreported and underrecognized. In cohort studies, rates may rise up to 8% of transfused patients. 3, 4 Only a few studies have assessed outcomes and risk factors of TACO. These studies are mainly based on a retrospective database or limited to specific populations. [5] [6] [7] A better understanding of the risk factors of TACO could help to prevent such a complication and to implement early management when TACO occurs.
The present study aimed at assessing the prevalence and morbidity associated with TACO and determining its risk factors in a cohort of nonselected patients. 
MATERIALS AND METHODS

Design
The present study was a case-control study. As the study was observational and data were collected anonymously, informed consent was waived.
The study was approved by the Institutional Review Board of the Nîmes University Hospital (Nîmes, France; IRB No. 16.07.01).
Study population
All TACO cases reported from January 1, 2014, to May 31, 2017, at the Nîmes University Hospital were included as cases. As the definition has been revised recently, 8 only cases with documented acute pulmonary edema were retained, and other clinical forms that might have matched with the proposed new definitions were discarded. If several episodes of TACO occurred for a patient, only the first episode was taken into account. The institution is an academic hospital that offers 951 beds and includes a wide range of medical and surgical specialties for a population pool of about one million inhabitants. As RBCs are the leading cause of TACO, according to previous studies, 6 only cases of TACO associated with RBC transfusion and with an imputability level graded as probable or definite were included. The French national drug agency (Agence Nationale de Sécurité du Médicament) definition of TACO was used. 9 The latter is concordant with the International Society of Blood Transfusion definition. 10 The diagnosis of TACO was retained in the presence of all of the following criteria: 1) new decline in respiratory status; 2) within 6 hours following RBC transfusion; 3) at least one clinical sign of pulmonary edema (e.g., orthopnea, crackles); 4) at least one paraclinical sign: biologic (elevated brain natriuretic peptide, pro-brain natriuretic peptide), chest imaging, echocardiography, or pulmonary artery catheter evidence of pulmonary edema; and 5) no evidence of transfusion-related acute lung injuries: low filling pressure, septic shock, acute respiratory distress syndrome.
The main clinical and paraclinical features are summarized in Fig. 1 .
Cases were reported by bedside physicians, investigated by the local transfusion practitioner, and subsequently reviewed and validated by the French national hemovigilance system as previously described.
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For each case, four controls were randomly selected among patients who received at least one RBC on the same day without experiencing any form of TACO. As all cases of TACO were adults, children under 16 were excluded from sampling lists.
Data collection
Demographic characteristics and clinical outcomes were extracted from the electronic medical records of the hospital. Based on previous studies, 5, 12, 13 the following data were collected: age, sex, weight, presence and type of surgery, and number and type of blood products transfused in the past 24 hours. Chronic use of loop diuretics (furosemide), chronic heart failure, atrial fibrillation, heart valve dysfunction, and chronic hypertension were considered present when documented in the patient's past medical history. Renal failure was defined using the estimated glomerular filtration rate by the Chronic Kidney Disease Epidemiology Collaboration equation on the last laboratory result available. Renal failure was deemed present when the estimated glomerular filtration rate by the Chronic Kidney Disease Epidemiology Collaboration equation was lower than 60 mL/min. For each blood product, the reason for prescription is indicated in a digital form by the physician in charge of the patient. Data on chronic anemia and hemorrhagic shock were obtained this way.
Statistical analysis
Quantitative variables are expressed as median and interquartile range, and qualitative variables are presented as number and percentages. Comparisons between cases and controls were performed using Fisher's exact test or chisquared test for qualitative variables as appropriate. The Student t test and the Mann-Whitney test were used for quantitative variables.
Then, to perform a logistic regression, quantitative variables were stratified into two classes after an analysis by percentile. Briefly, each quantitative variable was expressed in percentile by groups (TACO and control) per 5% increment. The values of the variable between both groups by percentile were compared. The first percentile for which this difference was above 10% was chosen as the cutoff value.A multivariable logistic regression was then performed, including variables with a p value less than 0.10. Backward elimination was used with a threshold of p = 0.05 to exclude variables from the model. Statistical software for epidemiology (Epi Info 3, Centers for Disease Control and Prevention) was used.
RESULTS
During the study period, 37,029 RBCs were transfused to 8787 patients, who received a total of 47,324 units of labile blood products. Among them, 60 cases of TACO with acute pulmonary edema were reported and included as cases, and 240 controls were consequently randomly selected (Fig. 2) . The overall reported incidence of TACO was one case for every 616 RBCs or a ratio of 162 TACOs/100,000 RBC transfused. During the study period, 1 in 146 transfused patients experienced TACO, and 3 of the patients died from TACO (mortality, 5%). Demographic characteristics of patients and outcomes are displayed in Table 1 . The number of blood product transfused by year, transfusion adverse reactions, and TACO are exposed in Table 2 .
Mortality 28 days after transfusion was significantly higher for TACOs (22%) than for controls (11%) (odds ratio [OR], 2.28; 95% confidence interval [CI], 1.09-4.76; p = 0.032), as were overall hospitalization duration and duration of hospitalization after transfusion (Table 1) .
In univariable analysis, the following risk factors were significantly associated with TACO: concomitant one or more platelet concentrates transfused, a low body weight (<46 kg), chronic use of loop diuretics, hemorrhagic shock, chronic heart failure, chronic hypertension (whether treated or not), and the presence of renal failure.
Logistic regression identified four independent risk factors: hemorrhagic shock (OR, 12; 95% CI, 2.9-50; p < 0.001), a low body weight (<46 kg; OR, 7.9; 95% CI, 2.3-26.8; p = 0.001), chronic use of loop diuretics (OR, = 6.5; 95% CI, 2.3-26.8; p < 0.001), and chronic hypertension (OR, = 4.1; 95% CI, 2.0-8.5; p < 0.001).
The results of univariable and multivariable analysis are presented in Table 3 .
DISCUSSION
In the present study, TACO was frequent and associated with higher mortality and a longer hospital stay. The probability that a patient transfused in our institution suffers from TACO was slightly below 1%. Although this figure is much higher than those usually reported by national hemovigilance systems, 8, 9 it is still lower than ratios found in publications involving selected patients, some of them being prospective. 14 However, our study population came from all wards of our institution, which admits patients from all the geographic areas, regardless of the complexity of their condition. Therefore, it is more likely to be representative of the general population of transfused patients. A 5% mortality rate of TACO was observed. These data are compatible with those from Serious Hazards of Transfusion, reporting 14 deaths among 86 probable or definite TACO cases in 2016. 8 Considering the probable unreported cases of TACO, fatality figures could be much higher than currently published. The four independent risk factors identified by the present study were hemorrhagic shock, a low body weight (<46 kg), chronic use of loop diuretics, and chronic hypertension. These risk factors are simple, readily available, and easy to identify by clinicians. This may help to prevent TACO by clinicians being cautious in these particular populations.
Hemorrhagic shock was associated with the highest odds ratio, although this risk factor was only described by Menis et al. 6 A large amount of blood component as well as nonsanguineous fluid volume is probably involved, though an inflammatory mechanism may play a role. 15 Chronic use of diuretics was previously identified by Piccin and colleagues 13 and is likely to be related to a previous episode of acute pulmonary edema or congestive heart failure even if not clearly stated in medical records. In the multivariable analysis, this association between diuretics and TACO has probably attenuated the statistical relationship between congestive heart failure and TACO. The latter explains that, unlike Menis et al., 6 chronic heart failure was not found to be an independent risk factor in the present study. The number of transfused RBC does not appear as a risk factor. However, the vast majority of patients only received one or two RBC. It is well known that nearly half of TACO cases happen during the transfusion of a single RBC or the first of a batch. 12 Finally, the difference between men and women in terms of risk of TACO found in some studies may be explained by lower body weight in women.
There are several limitations to our study. First, the surveillance system is declarative leading to a probable underreporting of transfusion adverse reactions. Then, data on the duration of transfusion or fluid balance were lacking especially for outpatients, thought usually associated with TACO. 7 Left ventricular function of the patients were investigated from the medical records; however, these data were so sparse that it could not be integrated in the analysis. Instead, patients with a left ventricular ejection fraction less than 40% were considered to have chronic heart failure. Finally, ultrasound data evaluating diastolic cardiac function were so rare that we could not study it as a risk factor. However, chronic hypertension and use of loop diuretics are known to be related with such cardiac dysfunction. 16 In conclusion, TACO was frequent and associated with poor outcome in our nonselected population. Four risk factors were found to be independently associated with TACO: hemorrhagic shock, low body weight, chronic use of diuretics, and chronic hypertension.
